ANI Pharmaceuticals, Inc.
ANIP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $145 | $221 | $48 | $100 |
| Short-Term Investments | $6 | $0 | $0 | $0 |
| Receivables | $222 | $162 | $165 | $129 |
| Inventory | $137 | $111 | $105 | $82 |
| Other Curr. Assets | $18 | $25 | $25 | $11 |
| Total Curr. Assets | $528 | $520 | $344 | $322 |
| Property Plant & Equip (Net) | $57 | $45 | $43 | $53 |
| Goodwill | $60 | $28 | $28 | $28 |
| Intangibles | $542 | $209 | $252 | $294 |
| Long-Term Investments | $0 | $6 | $0 | $5 |
| Tax Assets | $85 | $91 | $81 | $68 |
| Other NC Assets | $12 | $6 | $11 | $2 |
| Total NC Assets | $756 | $385 | $416 | $450 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,284 | $904 | $760 | $772 |
| Liabilities | – | – | – | – |
| Payables | $46 | $37 | $29 | $23 |
| Short-Term Debt | $9 | $1 | $1 | $1 |
| Tax Payable | $7 | $8 | $0 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $132 | $100 | $69 | $60 |
| Total Curr. Liab. | $194 | $145 | $99 | $88 |
| LT Debt | $615 | $285 | $286 | $287 |
| Deferred Rev, NC | $0 | $0 | $0 | -$9 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $9 |
| Other NC Liab. | $47 | $17 | $36 | $39 |
| Total NC Liab. | $661 | $301 | $322 | $325 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $855 | $447 | $422 | $413 |
| Equity | – | – | – | – |
| Pref Stock | $25 | $25 | $25 | $25 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$100 | -$80 | -$97 | -$48 |
| AOCI | $5 | $9 | $12 | -$3 |
| Other Equity | $499 | $504 | $399 | $385 |
| Total Equity | $429 | $458 | $339 | $359 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,284 | $904 | $760 | $772 |
| Net Debt | $479 | $65 | $238 | $187 |